Zobrazeno 1 - 10
of 28
pro vyhledávání: '"59"'
Publikováno v:
Open Forum Infectious Diseases
Background In February 2010, the Food and Drug Administration (FDA) licensed the 13-valent pneumococcal conjugate vaccine (PCV13) for use in children aged 6 weeks through 59 months. The Advisory Committee on Immunization Practices (ACIP) recommended
Autor:
Elizabeth R Brown, Anna Bershteyn, Helen C Stankiewicz Karita, Christine Johnston, Lorna Thorpe, Angelica Kottkamp, Kathleen Neuzil, Miriam K Laufer, Meagan Deming, Michael K Paasche-Orlow, Patricia J Kissinger, Alfred Luk, Kristopher M Paolino, Raphael J Landovitz, Risa Hoffman, Torin Schaafsma, Meighan L Krows, Katherine Thomas, Susan Morrison, Lara Kidoguchi, Mark H Wener, Alexander L Greninger, Meei-Li Huang, Keith Jerome, Anna Wald, Connie Celum, Helen Y Chu, Jared M Baeten
Publikováno v:
Open Forum Infectious Diseases
Background Prevention interventions for coronavirus disease (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), are currently limited to non-pharmaceutical strategies. Observational and laboratory data suggested that h
Autor:
Hendri Wijaya, Khalid B. Beshir, Sarah G. Staedke, Chairuddin P. Lubis, Colin J. Sutherland, Munar Lubis, Inke Nadia D. Lubis
Publikováno v:
Open Forum Infectious Diseases. 7
Background We assessed the efficacy of artemisinin-based combination therapies for treatment of uncomplicated falciparum malaria, with or without co-infecting Plasmodium spp., in Sumatera, Indonesia. Methods Febrile patients aged >6 months with uncom
Autor:
Federico Conti, Giovanni Francesco Pellicanò, Barbara Menzaghi, Giuseppe Vittorio De Socio, Laura Valsecchi, Giancarlo Orofino, Paolo Bonfanti, Cesare Bolla, Lucia Taramasso, Benedetto Maurizio Celesia, Antonio Di Biagio, Leonardo Calza, Elena Ricci, Francesca Vichi, Antonio Mastroianni, Paolo Maggi, Goffredo Angioni, Giordano Madeddu, Layla Pagnucco, Chiara Dentone, Nicola Squillace, Antonio Cascio, Canio Martinelli, Giovanni Cenderello, Katia Falasca
Publikováno v:
Open Forum Infectious Diseases
BackgroundAn unexpected excess in weight gain has recently been reported in the course of dolutegravir (DTG) treatment. The aim of the present study was to investigate whether weight gain differs among different DTG-containing regimens.MethodsAdult n
Autor:
Samuel Simon, Sahil Bhatia, Taylor Morrisette, Joshua R Rosenberg, Abdalhamid M Lagnf, Michael J. Rybak, Sarah M Melvin, Trang D Trinh, Kimberly C. Claeys, Sandra J Estrada, Molly E. Steed, Evan J Zasowski, Susan L. Davis, Sarah C J Jorgensen
Publikováno v:
Open Forum Infectious Diseases
Background We conducted this study to describe the clinical characteristics, microbiology, and outcomes of patients treated with ceftazidime-avibactam (CZA) for a range of multidrug-resistant Gram-negative (MDR-GN) infections. Methods This is a multi
Autor:
William J. Towner, Shannon Schrader, Steven Weinheimer, Edwin DeJesus, Jerome De Vente, Colleen S. McGary, Pedro Mesquita, Mohammed Zogheib
Publikováno v:
Open Forum Infectious Diseases
Background Third line antiretroviral regimens have been associated with suboptimal virologic suppression, due to drug cross-resistance and regimen complexity. Yet, in treatment-experienced (TE) HIV patients, ART durability is essential for preventing
Publikováno v:
Open Forum Infectious Diseases
Background The use of rapid molecular diagnostic testing to identify microorganisms and resistance markers has great potential to optimize medical care and assist with antimicrobial stewardship. We implemented the Verigene bloodstream infection testi
Autor:
Catherine DeVoe, Alexandra Hilts-Horeczko, Samantha Shenoy, Lusha Wang, Sarah B Doernberg, John H Dzundza, Larissa R. Graff, Rebecca L. Olin, Rosa Rodriguez-Monguio, Luke Strnad, Lloyd E. Damon, Trang D Trinh, Laura M Griffith
Publikováno v:
Open Forum Infectious Diseases
Background Febrile neutropenia (FN) is a common complication of cancer therapy and often necessitates prolonged antibiotic treatment. Antibiotic de-escalation can be challenging given tenuous clinical status. Furthermore, a microbiological or clinica
Publikováno v:
Open Forum Infectious Diseases
Background Acute otitis media (AOM) is the most common pediatric outpatient condition treated with antibiotics in the United States. Over 30% of children receive inappropriate antibiotics for AOM, contributing to increasing antimicrobial resistance a
Autor:
Érico Macedo Pacheco Alves, Joice Ribeiro Lopes, Bráulio Roberto Gonçalves Marinho Couto, Luciana Coelho Tanure, Flávio Henrique Batista de Souza, Rafaela Tonholli Pinho, Bárbara Caldeira Pires, Carlos Ernesto Ferreira Starling, Daniela Teixeira Ribeiro
Publikováno v:
Open Forum Infectious Diseases
Background Vancomycin-Resistant Enterococcus (VRE) is considered one of the main pathogens of hospital-acquired infections (HAI), responsible for high morbidity and mortality rates. HAI caused by this bacteria, especially in intensive care units (ICU